Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 5 μg | Estimated to ship onMay 25, 2026fromKuehne + Nagel Sp. z o.o. | PLN 2,370.00 |
About This Item
PLN 2,370.00
Estimated to ship onMay 25, 2026Details
biological source
human
Quality Level
assay
>95% (total protein)
form
liquid
specific activity
250-300 mU/mg
manufacturer/tradename
Chemicon®
concentration
0.2 μg/μL
NCBI accession no.
UniProt accession no.
shipped in
dry ice
Gene Information
human ... MMP13(4322)
General description
ProMMP-13 [Procollagenase-3] consists of 452 amino acids with a calculated Mr of 52.520 [Freije et al., 1994]. Due to N-linked glycosylation, the actual Mr is about 60000 Da [Knauper et al., 1996]. Within the protein the following domains and sequence regions can be distinguished [Freije et al., 1994; Knauper et al., 1996]: An N-terminal propeptide, which confers latency to the proenzyme, a Ca2+ and Zn2+-ion binding catalytic domain, a hinge region, and a C-terminal hemopexin-like domain. Latent procollagenase-3 can be activated by proteases such as stromelysin [ Knauper et al., 1996], gelatinase A, MT1-MMP and plasmin [ Knauper et al., 1996] or incubation with APMA Knauper et al., 1996]. The Mr of active collagenase-3 which begins with the N-terminal sequence YNVFPRTL is 48,000 Da.
Collagenase-3 hydrolyzes type II collagen 5- to 6- times faster than type I and type III collagens. The enzyme also exhibits high activity towards gelatin and it degrades SERPINS as a1-antichymotrypsin and plasminogen activator inhibitor-2 [Knauper et al., 1996]. Collagenase-3 is inhibited in a 1:1 stoichiometric fashion by TIMP-1, TIMP-2 and TIMP-3.
Collagenase-3 is expressed during fetal bone development [Stahlebackdahl, 1997]. In adult human tissues collagenase-3 has been detected only in pathological conditions: in malignant tumors [Freije et al., 1994], in chronic ulcers [Valaamo et al., 1997], in arthritic cartilage [Mitchell et al., 1996] and synovium [Wernicke et al., 1996].
Application
An aliquot of 19.5 μL procollagenase-3 is mixed with 0.5 μL APMA solution (40 mM p-aminophenyl mercuric acetate in DMSO) and the mixture is incubated for 30 minutes at 37°C. The mixture may be stored on ice until use for activity assays.
INHIBITORS:
MMP-13 is inhibited by TIMPs and by chelators of divalent cations such as EDTA or o-phenanthroline.
Physical form
Preparation Note
Analysis Note
Other Notes
Legal Information
Disclaimer
1 of 1
This Item | |||
|---|---|---|---|
| assay >95% (total protein) | assay - | assay ≥90% (SDS-PAGE) | assay ≥98% (HPLC), ≥98% (SDS-PAGE) |
| Gene Information human ... MMP13(4322) | Gene Information human ... MMP13(4322) | Gene Information - | Gene Information human ... MMP1(4312) |
| specific activity 250-300 mU/mg | specific activity - | specific activity ≥50 mU/mg protein | specific activity - |
| biological source human | biological source rabbit | biological source - | biological source human |
| concentration 0.2 μg/μL | concentration ~1 mg/mL | concentration - | concentration - |
| form liquid | form buffered aqueous solution | form liquid | form lyophilized |
Storage Class
12 - Non Combustible Liquids
wgk
WGK 1
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
A Chemicon comparative chart showing MMPs, classifications, weights, activating agents, conditions and related references.
Global Trade Item Number
| SKU | GTIN |
|---|---|
| CC1047 | 04053252277078 |



